Mumbai, India.

KRISHGEN BIOSYSTEMS announces the availablity of their revamped product line for bioprocess assays - KRIBIOLISA. These assays includes kits for testing of host cell proteins in ecoli, ppastoris, cho and others. Comparable features of these kits are their high sensitivity and competitive prices to offer affordable solutions to bioprocess manufacturers. 

the company's future plans include a broadening of this portfolio by offering wider assays and also breathe life in HCP testing by offering newer generation platforms.

KRISHGEN BIOSYSTEMS is an Indian SME rated by SMERA/DnB established in 2003 with annual revenues of USD5,0million with a primary focus on distribution activites.